Brentuximab vedotin plus bendamustine in relapsed or refractory Hodgkin's lymphoma: an international, multicentre, single-arm, phase 1-2 trial.

ABSTRACT:

SUBMITTER: O'Connor OA 

PROVIDER: S-EPMC9098158 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature